Skip to main content

Peer Review reports

From: Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial

Original Submission
10 Jun 2020 Submitted Original manuscript
30 Dec 2020 Author responded Author comments - Eli Mansour
Resubmission - Version 2
30 Dec 2020 Submitted Manuscript version 2
Publishing
6 Jan 2021 Editorially accepted
20 Jan 2021 Article published 10.1186/s13063-021-05027-9

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215